Clinical Trial Update: Aclidinium/Formoterol Fixed Combination Dose Finding Study [Phase 2]

View source ↗

Summary

This Phase 2 dose-finding trial evaluated a fixed-dose combination of aclidinium and formoterol for chronic obstructive pulmonary disease and has completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Aclidinium/Formoterol Fixed Dose Combination (aclidinium/formoterol fixed-dose combination)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Status: COMPLETED | Results posted: 2016-08-08